Your browser doesn't support javascript.
loading
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).
Kalff, Anna; Khong, Tiffany; Mithraprabhu, Sridurga; Bergin, Krystal; Reynolds, John; Bowen, Kathryn M; Thakurta, Anjan; Guzman, Roberto; Wang, Maria; Couto, Suzana; Ren, Yan; Spencer, Andrew.
Afiliação
  • Kalff A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital/Monash University , Melbourne , Australia.
  • Khong T; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital , Melbourne , Australia.
  • Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital/Monash University , Melbourne , Australia.
  • Bergin K; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital/Monash University , Melbourne , Australia.
  • Reynolds J; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital , Melbourne , Australia.
  • Bowen KM; Alfred Health and Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne , Australia.
  • Thakurta A; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital , Melbourne , Australia.
  • Guzman R; Celgene Corporation , Summit , NJ , USA.
  • Wang M; Celgene Corporation , San Diego , CA , USA.
  • Couto S; Celgene Corporation , San Diego , CA , USA.
  • Ren Y; Celgene Corporation , San Diego , CA , USA.
  • Spencer A; Celgene Corporation , San Diego , CA , USA.
Leuk Lymphoma ; 60(9): 2143-2151, 2019 09.
Article em En | MEDLINE | ID: mdl-31184224

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2019 Tipo de documento: Article